About This Desk

What this desk covers

New Age Peptide reads the published research on three compounds studied in the context of cellular aging: NAD+, MOTS-c, and Epitalon. They were not chosen because they are chemically related — they are not — but because they are three of the more prominent answers to the same question currently circulating in longevity research and longevity-adjacent communities: what, specifically, goes wrong inside an aging cell, and has anything been shown to slow it down?

Each compound gets its own page, laid out to the same structure: what it is, how it is proposed to work, what the published research actually found, and what cautions the literature itself raises. NAD+ leads the set because its human evidence is the deepest of the three. A comparison page puts all three side by side, and one shared reference list gathers every source drawn on across the site.

How this desk reads the literature

Three rules govern what appears on this site.

Every factual claim traces to a cited source. Peer-reviewed studies, reviews, and — where relevant — regulatory actions such as an FDA recall, gathered on the references page with DOIs and PubMed links where available. Where a claim comes from a review rather than a primary study, the page says so.

Evidence is reported at the scale it was actually generated. A cell-culture concentration is described as a cell-culture concentration, not implied to be a human dose. A mouse finding is described as a mouse finding. An observational cohort is described as observational, not as a randomized trial. This distinction matters more here than almost anywhere else on this site's broader network, because two of the three compounds — MOTS-c and Epitalon — have essentially no human interventional data, and it would be easy, and dishonest, to blur that gap.

Community reports are labeled, never smuggled in as findings. Where a page describes what people in research or longevity communities report experiencing, it says so explicitly and marks it anecdotal, not clinical evidence. Two of the three compounds on this desk (NAD+ and MOTS-c) simply have no such reports in the source material behind this site, and their pages say so rather than inventing a plausible-sounding anecdotal section.

The edges of this desk

New Age Peptide is not a pharmacy, clinic, telehealth platform, or vendor of any kind. Nothing on this site is sold, sourced, or brokered — no supplement, no research chemical — and no manufacturer or supplier pays for placement here. No clinician is on staff; nothing is diagnosed, and no dose, schedule, or route is recommended to any individual for any of the three compounds.

NAD+'s precursors are legally sold as dietary supplements in the US; MOTS-c and Epitalon are sold, where sold at all, only as research chemicals explicitly labeled not for human consumption. Anyone seeking guidance on using any of these compounds should take that question to a licensed clinician in their own jurisdiction. Corrections, citation fixes, or notes on newly published research are welcome by way of the contact page; requests for medical advice cannot be answered.